The  	The  	 DT	O
tumoral  	tumoral  	 NN	B-NP
A  	A  	 DT	O
genotype  	genotype  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
MGMT  	MGMT  	 NNP	I-NP
rs34180180  	rs34180180  	 NNP	O
single-nucleotide  	single-nucleotide  	 JJ	B-NP
polymorphism  	polymorphism  	 NN	I-NP
in  	in  	 IN	O
aggressive  	aggressive  	 JJ	B-NP
gliomas  	gliomas  	 NN	I-NP
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
shorter  	shorter  	 JJR	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
survival  	survival  	 NN	O
Malignant  	Malignant  	 NNP	B-NP
gliomas  	gliomas  	 NNS	I-NP
are  	are  	 VBP	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
primary  	primary  	 JJ	B-NP
brain  	brain  	 NN	I-NP
tumors 	tumors 	 NNS	I-NP
.  	.  	 .	O
Grade  	Grade  	 NNP	O
III  	III  	 NNP	O
and  	and  	 CC	O
IV  	IV  	 NNP	O
gliomas  	gliomas  	 VBZ	O
harboring  	harboring  	 VBG	B-NP
wild-type  	wild-type  	 JJ	I-NP
IDH1 	IDH1 	 CD	I-NP
/ 	/ 	 CD	O
2  	2  	 CD	O
are  	are  	 VBP	O
the  	the  	 DT	O
most  	most  	 RBS	O
aggressive 	aggressive 	 JJ	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
surgery  	surgery  	 NN	O
and  	and  	 CC	O
radiotherapy 	radiotherapy 	 NN	O
,  	,  	 ,	O
concomitant  	concomitant  	 NN	O
and  	and  	 CC	O
adjuvant  	adjuvant  	 JJ	B-NP
chemotherapy  	chemotherapy  	 NN	I-NP
with  	with  	 IN	O
temozolomide  	temozolomide  	 NNS	B-NP
( 	( 	 -LRB-	O
TMZ 	TMZ 	 NNP	B-NP
)  	)  	 -RRB-	O
significantly  	significantly  	 RB	O
improves  	improves  	 VBZ	O
overall  	overall  	 JJ	B-NP
survival  	survival  	 NN	I-NP
( 	( 	 -LRB-	O
OS 	OS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
methylation  	methylation  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
O 	O 	 NNP	I-NP
( 	( 	 -LRB-	I-NP
6 	6 	 CD	I-NP
) 	) 	 -RRB-	I-NP
-methylguanine-DNA  	-methylguanine-DNA  	 JJ	I-NP
methyltransferase  	methyltransferase  	 NNS	I-NP
( 	( 	 -LRB-	O
MGMT 	MGMT 	 NNP	B-NP
)  	)  	 -RRB-	O
promoter  	promoter  	 NN	O
is  	is  	 VBZ	O
predictive  	predictive  	 VBN	O
of  	of  	 IN	O
TMZ  	TMZ  	 NNP	B-NP
response  	response  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
prognostic  	prognostic  	 JJ	B-NP
marker  	marker  	 NN	I-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
outcome 	outcome 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
promoter  	promoter  	 NN	B-NP
regions  	regions  	 NNS	I-NP
the  	the  	 DT	O
methylation  	methylation  	 NN	B-NP
of  	of  	 IN	O
which  	which  	 WDT	O
correlates  	correlates  	 VBP	O
best  	best  	 RB	O
with  	with  	 IN	O
survival  	survival  	 NN	O
in  	in  	 IN	O
aggressive  	aggressive  	 JJ	B-NP
glioma  	glioma  	 NN	I-NP
and  	and  	 CC	O
whether  	whether  	 IN	O
the  	the  	 DT	O
promoter  	promoter  	 FW	B-NP
methylation  	methylation  	 FW	I-NP
status  	status  	 FW	I-NP
predictive  	predictive  	 FW	I-NP
value  	value  	 NN	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
refined  	refined  	 VBN	O
or  	or  	 CC	O
improved  	improved  	 VBN	O
by  	by  	 IN	O
other  	other  	 JJ	O
MGMT-associated  	MGMT-associated  	 JJ	B-NP
molecular  	molecular  	 JJ	I-NP
markers  	markers  	 NNS	I-NP
are  	are  	 VBP	O
not  	not  	 RB	O
precisely  	precisely  	 RB	O
known 	known 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
87  	87  	 CD	O
malignant  	malignant  	 JJ	O
gliomas  	gliomas  	 NNS	B-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
radiotherapy  	radiotherapy  	 NN	O
and  	and  	 CC	O
TMZ-based  	TMZ-based  	 JJ	B-NP
chemotherapy 	chemotherapy 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
retrospectively  	retrospectively  	 VBP	O
determined  	determined  	 VBN	O
the  	the  	 DT	O
MGMT  	MGMT  	 FW	B-NP
promoter  	promoter  	 FW	I-NP
methylation  	methylation  	 FW	I-NP
status 	status 	 FW	I-NP
,  	,  	 ,	O
genotyped  	genotyped  	 FW	B-NP
single  	single  	 FW	I-NP
nucleotide  	nucleotide  	 FW	I-NP
polymorphisms  	polymorphisms  	 FW	I-NP
( 	( 	 -LRB-	O
SNPs 	SNPs 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
promoter  	promoter  	 NN	B-NP
region  	region  	 NN	I-NP
and  	and  	 CC	O
quantified  	quantified  	 JJ	O
MGMT  	MGMT  	 NNP	B-NP
mRNA  	mRNA  	 JJ	I-NP
expression  	expression  	 NN	I-NP
level 	level 	 NN	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
of  	of  	 IN	O
these  	these  	 DT	O
variables  	variables  	 NNS	O
was  	was  	 VBD	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
each  	each  	 DT	O
other  	other  	 JJ	O
and  	and  	 CC	O
with  	with  	 IN	O
the  	the  	 DT	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
OS 	OS 	 NNP	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
found  	found  	 VBD	O
that  	that  	 DT	O
methylation  	methylation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
CpG  	CpG  	 JJ	I-NP
sites  	sites  	 NNS	I-NP
within  	within  	 IN	O
MGMT  	MGMT  	 NNP	B-NP
exon  	exon  	 VBD	I-NP
1  	1  	 CD	O
best  	best  	 JJS	O
correlated  	correlated  	 NN	O
with  	with  	 IN	O
OS  	OS  	 NNP	B-NP
and  	and  	 CC	O
MGMT  	MGMT  	 NNP	B-NP
expression  	expression  	 NN	I-NP
levels 	levels 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
confirmed  	confirmed  	 VBD	O
MGMT  	MGMT  	 NNP	B-NP
methylation  	methylation  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
stronger  	stronger  	 JJR	O
independent  	independent  	 JJ	O
prognostic  	prognostic  	 JJ	B-NP
factor  	factor  	 NN	I-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
MGMT  	MGMT  	 NNP	B-NP
transcription  	transcription  	 NN	I-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
main  	main  	 JJ	O
finding  	finding  	 NN	O
is  	is  	 VBZ	O
that  	that  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
only  	only  	 RB	O
the  	the  	 DT	O
A  	A  	 DT	O
allele  	allele  	 NN	B-NP
at  	at  	 IN	O
the  	the  	 DT	O
rs34180180  	rs34180180  	 NNP	O
SNP  	SNP  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
shorter  	shorter  	 JJR	O
OS 	OS 	 NNP	B-NP
,  	,  	 ,	O
independently  	independently  	 RB	O
of  	of  	 IN	O
the  	the  	 DT	O
MGMT  	MGMT  	 FW	B-NP
methylation  	methylation  	 FW	I-NP
status 	status 	 FW	I-NP
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
clinic 	clinic 	 NN	O
,  	,  	 ,	O
rs34180180  	rs34180180  	 NNP	O
SNP  	SNP  	 NNP	B-NP
genotyping  	genotyping  	 NN	I-NP
could  	could  	 MD	O
improve  	improve  	 VB	O
the  	the  	 DT	O
prognostic  	prognostic  	 JJ	B-NP
value  	value  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
MGMT  	MGMT  	 NNP	I-NP
promoter  	promoter  	 NN	I-NP
methylation  	methylation  	 NN	I-NP
assay  	assay  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
aggressive  	aggressive  	 JJ	B-NP
glioma  	glioma  	 NNS	I-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
TMZ 	TMZ 	 NNP	B-NP
.  	.  	 .	O
